J&J Hid Topamax Birth Defect Risks, Philly Jury Hears

Law360, Philadelphia (February 24, 2014, 5:55 PM EST) -- A Johnson & Johnson subsidiary failed to adequately warn parents about the risk of birth defects associated with the epilepsy and migraine drug Topamax, an attorney for the family of a 5-year-old boy born with a cleft palate told a Philadelphia jury on Monday.

Scott Love, an attorney with Clark Love & Hutson representing the family of 5-year-old Josiah Brown, told a state jury during opening arguments that the failure of J&J subsidiary Janssen Pharmaceuticals Inc. to provide information to doctors about the possibility of birth...
To view the full article, register now.